ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,083, issued on March 31, was assigned to University of Virginia Patent Foundation (Charlottesville, Va.) and Virginia Tech Intellectual Properties Inc. (Blacksburg, Va.).

"Inhibitors of spinster homolog 2 (SPNS2) for use in therapy" was invented by Kevin R. Lynch (Charlottesville, Va.), Yugesh Kharel (Charlottesville, Va.), Webster L. Santos (Blacksburg, Va.), Ashley Peralta (Blacksburg, Va.), Russell G. Fritzemeier (Christiansburg, Va.) and Daniel Foster (Blacksburg, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides SPNS2 inhibitor compounds according to Formula I and their pharmaceutically acceptable salts, and/or...